Enrico Bucci

University of California, Los Angeles — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

43h-index7.8kcitations306works0.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hemoglobin structure and function(150), Neonatal Health and Biochemistry(51), Erythrocyte Function and Pathophysiology(35), Heme Oxygenase-1 and Carbon Monoxide(34), Protein Structure and Dynamics(31)

Publications306 total

Low-Cost Mechanism-Informed Features Enable Transferable Enantioselectivity Predictions from Sparse Data
2025
Development, Application, and Mechanistic Interrogation of a Dual Ni Catalysis Approach to Photoredox-Based C(sp <sup>3</sup> )–C(sp <sup>3</sup> ) Cross-Coupling
Journal of the American Chemical Society·2025Open Access
Measles and public health: an integrative approach
Biology Direct·2025Open Access
Castalin Induces ROS Production, Leading to DNA Damage and Increasing the Activity of CHK1 Inhibitor in Cancer Cell Lines
Antioxidants·2025Open Access
Measles and Public Health: An Integrative Approach
2025Open Access
Low-Cost Mechanism-Informed Features Enable Transferable Enantioselectivity Predictions from Sparse Data
2025Open Access
Development, Application, and Mechanistic Interrogation of a Dual Ni Catalysis Approach to Photoredox-Based C(sp3)–C(sp3) Cross-Coupling
2025Open Access
The Synthetic Image Crisis in Science
American Journal of Hematology·2025· 2 cited
A Multicenter Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia
Infectious Diseases and Therapy·2022· 24 citedOpen Access
Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variants
Cell Death and Disease·2022· 20 citedOpen Access
SCIENTIFIC FRAUD Part II: From Past to Present, Facts and Analyses
European Review·2022· 2 cited
SCIENTIFIC FRAUD Part I: Definition, General Concepts, Historical Cases
European Review·2022· 2 cited
Characterization of raloxifene as potential pharmacological agent against SARS-CoV-2 and its variants
2021· 1 citedOpen Access
Repurposing the estrogen receptor modulator raloxifene to treat SARS-CoV-2 infection
Cell Death and Differentiation·2021· 65 citedOpen Access
Data discrepancies and substandard reporting of interim data of Sputnik V phase 3 trial
The Lancet·2021· 55 citedOpen Access
Coronavirus 2019 Infectious Disease Epidemic: Where We Are, What Can Be Done and Hope For
Journal of Thoracic Oncology·2021· 52 citedOpen Access
Etica dei vaccini. Tra libertà e responsabilità
2021
Correction: P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma
Cell Death and Disease·2020· 4 citedOpen Access
Safety and efficacy of the Russian COVID-19 vaccine: more information needed
The Lancet·2020· 85 citedOpen Access
P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma
Cell Death and Disease·2020· 46 citedOpen Access
page 1 of 16Next →

Frequent Co-authors

Clara Fronticelli(14), Jeffries Wyman(8), Raymond C. Koehler(8), Eraldo Antonini(7), A. Rossi‐Fanelli(7), John A. Ulatowski(7), Herman Kwansa(5), Anna Rażyńska(5), Richard J. Traystman(4), Paolo Abrescia(3), Yufang Shi(2), Gerry Melino(2), Maurizio Brunori(2), Annette Rebel(2), Emilia Chiancone(2), Konstantin Andreev(2), Raffaele Calogero(2), Ernesto Carafoli(2), Roland Zell(2), Barbara Matheson-Urbaitis(2)